Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons

The House Judiciary Committee has subpoenaed Dr. Philip Dormitzer, a former Pfizer Inc. (NYSE:PFE) executive, in connection with an investigation into claims that the company intentionally delayed the release of clinical testing results for its COVID-19 vaccine until after the 2020 presidential election.

The move signals an escalation in the panel's probe into whether political considerations influenced Pfizer's vaccine announcement timeline.

Dormitzer, who later joined British drugmaker GSK Plc (NYSE:GSK), is considered a key witness in the inquiry.

Also Read: Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data

Benzinga reached out to Pfizer for comment.

According to the committee, he has not voluntarily complied with previous ...